A prediction model for central venous catheter-related thrombosis in patients with newly-diagnosed acute myeloid leukemia: A derivation cohort analysis-Reference-Cited by-同舟云学术

A prediction model for central venous catheter-related thrombosis in patients with newly-diagnosed acute myeloid leukemia: A derivation cohort analysis

Published:2022-07 Issue: Volume:101 Page:68-75
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Perek Shay^ORCID,Khatib Alaa,Izhaki Niv,Khalaila Ali Sleman,Brenner Benjamin,Horowitz Netanel A.^ORCID

Publisher

Elsevier BV

Subject

Internal Medicine

Reference45 articles.

1. Venous thromboembolism in cancer patients: a population-based cohort study;Mulder;Blood,2021

2. Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment;Chojnowski;Leuk Lymphoma,1999

3. Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?;Rickles;Thromb Res,2007

4. Incidence and outcomes of catheter related thrombosis (CRT) in patients with acute leukemia using a platelet-adjusted low molecular weight heparin regimen;Htun;J Thromb Thrombolysis,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and validation of a predictive nomogram for central venous catheter-related thrombosis in cancer patients: a retrospective nested case-control study;Frontiers in Oncology;2024-08-16

2. Development of a Machine Learning-Based Model for Predicting the Incidence of Peripheral Intravenous Catheter-Associated Phlebitis;The Journal of Critical Care Medicine;2024-07-01

3. Prevalence of PICC-related thrombosis in patients with hematological malignancies: a systematic review;Supportive Care in Cancer;2024-06-26

4. Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review;BMC Cancer;2024-04-19

5. Thrombosis in Myeloid Malignancies: From CHIP to AML;Cardiovascular & Hematological Disorders-Drug Targets;2024-03